Publications by authors named "J Di Cristofaro"

Article Synopsis
  • - Edoxaban is a selective oral medication used to prevent strokes in patients with non-valvular atrial fibrillation, but it is not safe for individuals with severe liver disease.
  • - Common side effects of edoxaban include elevated levels of serum bilirubin and gamma-glutamyl transpeptidase.
  • - An 82-year-old man with liver cancer experienced a severe and fatal condition called vanishing bile duct syndrome shortly after starting edoxaban, marking the first documented case linking the drug to this syndrome.
View Article and Find Full Text PDF

Red blood cell (RBC) transfusion, limited by patient alloimmunization, demands accurate blood group typing. The Rh system requires specific attention due to the limitations of serological phenotyping methods. Although these have been compensated for by molecular biology solutions, some RhCE ambiguities remain unresolved.

View Article and Find Full Text PDF

We reported a case of blood culture-negative infective endocarditis on a native valve, where the clinical presentation was exclusively related to extensive cerebral ischemia secondary to multiple systemic septic cardioembolic events. The cause was ascribed to subacute infection, presumably transmitted by cat scratch, documented by positive serologic findings.

View Article and Find Full Text PDF

Red blood cell (RBC) transfusion remains a critical component in caring for the acute and chronic complications of sickle cell disease (SCD). Patient alloimmunisation is the main limitation of transfusion, which can worsen anaemia and lead to delayed haemolytic transfusion reaction or transfusion deadlock. Although biological risk factors have been identified for immunisation, patient alloimmunisation remains difficult to predict.

View Article and Find Full Text PDF